Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients . (2012). Journal of Cancer Research Updates, 1(1),  44-48. https://doi.org/10.6000/1929-2279.2012.01.01.08